Continuing enzalutamide with docetaxel in castration-resistant prostate cancer

被引:1
|
作者
Shiota, Masaki [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 8128582, Japan
来源
LANCET ONCOLOGY | 2022年 / 23卷 / 11期
关键词
D O I
10.1016/S1470-2045(22)00614-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1345 / 1347
页数:3
相关论文
共 50 条
  • [1] Enzalutamide in Castration-Resistant Prostate Cancer
    Bregni, Giacomo
    Rebuzzi, Sara E.
    Fornarini, Giuseppe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1380 - 1381
  • [2] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312
  • [3] Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
    Schrader, Andres Jan
    Boegemann, Martin
    Ohlmann, Carsten-H.
    Schnoeller, Thomas J.
    Krabbe, Laura-Maria
    Hajili, Turkan
    Jentzmik, Florian
    Stoeckle, Michael
    Schrader, Mark
    Herrmann, Edwin
    Cronauer, Marcus V.
    [J]. EUROPEAN UROLOGY, 2014, 65 (01) : 30 - 36
  • [4] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Schmid, Sebastian Christoph
    Geith, Alexander
    Boeker, Alena
    Tauber, Robert
    Seitz, Anna Katharina
    Kuczyk, Markus
    von Klot, Christoph
    Gschwend, Juergen Erich
    Merseburger, Axel Stuart
    Retz, Margitta
    [J]. ADVANCES IN THERAPY, 2014, 31 (02) : 234 - 241
  • [5] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sebastian Christoph Schmid
    Alexander Geith
    Alena Böker
    Robert Tauber
    Anna Katharina Seitz
    Markus Kuczyk
    Christoph von Klot
    Jürgen Erich Gschwend
    Axel Stuart Merseburger
    Margitta Retz
    [J]. Advances in Therapy, 2014, 31 : 234 - 241
  • [6] Enzalutamide Treatment in Metastatic Castration-resistant Prostate Cancer: Before and after Docetaxel
    Bilgetekin, Irem
    Basal, Fatma Bugdayci
    Cinkir, Havva Yesil
    Esin, Ece
    Oksuzoglu, Berna
    Demirci, Umut
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (08): : 815 - 821
  • [7] Enzalutamide in Castration-Resistant Prostate Cancer Reply
    Hussain, Maha
    Saad, Fred
    Sternberg, Cora N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1381 - 1381
  • [8] Enzalutamide: A Review in Castration-Resistant Prostate Cancer
    Lesley J. Scott
    [J]. Drugs, 2018, 78 : 1913 - 1924
  • [9] ENZALUTAMIDE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
    Ha, Y-S
    Goodin, S.
    DiPaola, R. S.
    Kim, I. Y.
    [J]. DRUGS OF TODAY, 2013, 49 (01) : 7 - 13
  • [10] Enzalutamide for Patients with castration-resistant Prostate Cancer
    Kessing, Richard
    [J]. AKTUELLE UROLOGIE, 2020, 51 (01)